PPARG and pemphigus foliaceus: In this report, we showed that PPARγ expression was greatly reduced in the rat PF model, and PPARγ agonists rosiglitazone and 15d-PGJ2 repressed PF progression, while PPARγ antagonist GW9662 promoted PF development in rat model.